Eli Lilly and Company
Rosemarie Kelly, 317-433-0150

Eli Lilly and Company (NYSE:LLY) today announces the addition of more robust
content and a more user-friendly format to www.LillyConnect.com, a multi-brand,
interactive Web site with e-Detailing capabilities that gives health care
professionals instant access to in-depth product and disease information.

LillyConnect.com delivers information by integrating the Internet with
traditional sales activity for Strattera(R) (atomoxetine HCl), Evista(R)
(raloxifene HCl), Prozac(R) Weekly(TM) (fluoxetine HCl) and insulin products
(Humalog(R) Mix75/25(TM) (75% insulin lispro protamine suspension and 25%
insulin lispro injection (rDNA origin)), Humalog(R) (insulin lispro injection
(rDNA origin)), Humulin(R) (REGULAR insulin human injection, usp (rDNA origin)).
Information about other Lilly products will be added to the site in the future.

To access LillyConnect.com, health care professionals register with the site to
receive personalized Lilly product and disease state information that fits their
area of interest and specialty. All content is password protected.

LillyConnect now offers:

    --  Improved navigation and content areas for product and disease state
        information

    --  assessment/diagnostic tools physicians can use with their patients

    --  interactive, self-directed informational presentations that describe a
        product's use and efficacy

    --  additional product and disease state webcasts and audio presentations.

"LillyConnect.com is a health care professional-dedicated portal, a one-stop
shop where health care professionals can seek information about Lilly products
and related diseases," said Gino Santini, president of Lilly U.S. operations.
"Our enhancements to the Web site place more information at physicians'
fingertips - information that is tailored specifically to their area of
expertise - as well as make available more interactive Web presentations that
physicians can do on their own time."

In addition to clinical, product, and disease state information, the site also
offers patient education materials that health care professionals may print to
give to patients during office visits, Lilly product safety and prescribing
information, Lilly patient assistance information, links to professional
meetings and continuing medical education courses, and access to clinical trial
information and medical society Web sites.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing
portfolio of first-in-class and best-in-class pharmaceutical products by
applying the latest research from its own worldwide laboratories and from
collaborations with eminent scientific organizations. Headquartered in
Indianapolis, Ind., Lilly provides answers - through medicines and information -
for some of the world's most urgent medical needs. Additional information about
Lilly is available at www.lilly.com.

-------------------------------------------------------
Strattera(R) (atomoxetine hydrochloride, Lilly)
Evista(R) (raloxifene hydrochloride, Lilly)
Humalog(R) Mix75/25(TM) (75% insulin protamine suspension 
 and 25% insulin lispro injection (rDNA origin), Lilly)
Humalog(R) (insulin lispro injection (rDNA origin), Lilly) 
Humulin(R) (REGULAR insulin human injection, usp (rDNA origin), Lilly) 
Prozac(R)Weekly(TM) (fluoxetine hydrochloride, Lilly)